Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1

This study has been completed.
Sponsor:
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00078130
First received: February 19, 2004
Last updated: April 13, 2010
Last verified: April 2010

February 19, 2004
April 13, 2010
July 2003
January 2006   (final data collection date for primary outcome measure)
Opiate abstinence
Not Provided
Complete list of historical versions of study NCT00078130 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1
Bup/Nx - Facilitated Rehab for Opioid Dependent Adolescents

The purpose of this study is to compare two 3-month treatments for adolescents/young adults who are addicted to heroin: buprenorphine/naloxone combined with psychosocial therapy and treatment as usual, a 7-14 day detoxification with buprenorphine and three weeks of psychosocial therapy.

Not Provided
Interventional
Phase 3
Primary Purpose: Treatment
Opioid-Related Disorders
Drug: Buprenorphine/naloxone
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
223
January 2006
January 2006   (final data collection date for primary outcome measure)

Male and non-pregnant female subjects seeking outpatient treatment for opioid dependence with physiological features without serious medical or psychiatric disorders.

Both
14 Years to 21 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00078130
NIDA-CTN-0010-1
Yes
George Woody, M.D., University of Pennsylvania
University of Pennsylvania
Not Provided
Principal Investigator: George Woody, M.D. University of Pennsylvania
National Institute on Drug Abuse (NIDA)
April 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP